S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
NASDAQ:BTTX

Better Therapeutics - BTTX Earnings Date, Estimates & Call Transcripts

$1.80
-0.21 (-10.45%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.75
$2.02
50-Day Range
$1.39
$2.77
52-Week Range
$0.91
$29.40
Volume
357,070 shs
Average Volume
3.23 million shs
Market Capitalization
$42.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00

Earnings Summary

Upcoming
Earnings Date
Aug. 11Confirmed
Actual EPS
(May. 13)
-$0.41 Missed By -$0.11
Consensus EPS
(May. 13)
-$0.30
Skip Charts & View Estimated and Actual Earnings Data

BTTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BTTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Better Therapeutics Analyst Forecasts

Current Year EPS Consensus Estimate: $-1.99 EPS
Next Year EPS Consensus Estimate: $-5.74 EPS

BTTX Earnings Date and Information

Better Therapeutics last announced its earnings results on May 13th, 2022. The reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.11. Better Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Better Therapeutics are expected to decrease in the coming year, from ($1.99) to ($5.74) per share. Better Therapeutics has confirmed that its next quarterly earnings report will be published on Thursday, August 11th, 2022. Better Therapeutics will be holding an earnings conference call on Thursday, August 11th at 8:30 AM Eastern. Interested parties can register for or listen to the call..

Better Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/11/2022
(Confirmed)
 ($0.47)       
5/13/2022Q1 2022($0.30)($0.41)($0.11)($0.41)    
3/28/2022Q4 2021($0.35)($0.71)($0.36)($0.71)












Better Therapeutics Earnings - Frequently Asked Questions

When is Better Therapeutics's earnings date?

Better Therapeutics has confirmed that its next quarterly earnings data will be published on Thursday, August 11th, 2022. Learn more on BTTX's earnings history.

Did Better Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Better Therapeutics (NASDAQ:BTTX) missed the analysts' consensus estimate of ($0.30) by $0.11 with a reported earnings per share (EPS) of ($0.41). Learn more on analysts' earnings estimate vs. BTTX's actual earnings.

How can I listen to Better Therapeutics's earnings conference call?

The conference call for Better Therapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Better Therapeutics's conference call transcript?

The conference call transcript for Better Therapeutics's latest earnings report can be read online. Read Transcript

How much revenue does Better Therapeutics generate each year?

Better Therapeutics (NASDAQ:BTTX) has a recorded annual revenue of $10,000.00.

How much profit does Better Therapeutics generate each year?

Better Therapeutics (NASDAQ:BTTX) has a recorded net income of -$40.33 million. BTTX has generated $0.00 earnings per share over the last four quarters.

What is Better Therapeutics's EPS forecast for next year?

Better Therapeutics's earnings are expected to decrease from ($1.99) per share to ($5.74) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:BTTX) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.